[1]郭琳娟,洪葵.成人先天性心脏病心律失常的诊断和治疗进展[J].心血管病学进展,2015,(6):752-755.[doi:10.3969/j.issn.1004-3934.2015.06.024]
 GUO Linjuan,HONG Kui.Advances in Diagnosis and Treatment of Adult Congenital Heart Disease with Arrhythmia[J].Advances in Cardiovascular Diseases,2015,(6):752-755.[doi:10.3969/j.issn.1004-3934.2015.06.024]
点击复制

成人先天性心脏病心律失常的诊断和治疗进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2015年6期
页码:
752-755
栏目:
综述
出版日期:
2016-06-20

文章信息/Info

Title:
Advances in Diagnosis and Treatment of Adult Congenital Heart Disease with Arrhythmia
作者:
郭琳娟洪葵
南昌大学第二附属医院心血管内科,江西 南昌 330006
Author(s):
GUO Linjuan HONG Kui
Cardiology Department, The Second Affiliated Hospital of Nanchang University, Nanchang 330006,Jiangxi,China
关键词:
先天性心脏病 心律失常 诊断 治疗
Keywords:
congenital heart disease arrhythmia diagnose therapy
分类号:
R541.1
DOI:
10.3969/j.issn.1004-3934.2015.06.024
文献标志码:
A
摘要:
先天性心脏病(CHD)治疗技术的快速进展使得在发达国家有超过90%的CHD儿童能存活到成年,导致成人CHD患者数量远远超过儿童CHD患者数量。心律失常患者可表现为从无症状到有致命性症状,其复杂性和治疗方面的挑战性,要求临床医生必须对患者进行实时监测、严格评估、综合考虑,最后选择最佳的治疗方案。现根据最新颁布的相关专家共识,就成人CHD心律失常患者的诊断和治疗进展进行阐述。
Abstract:
In developed countries,the rapid, aggressive and progressive treatment of congenital heart disease(CHD)enables more than 90% of CHD children to successfully grow into adults. As a result,the number of adult patients with CHD far outnumber that of pediatric CHD patients. Arrhythmia patients may have different manifestations from asymptomatic to fatal symptoms. Due to the complex and challenging of the treatment of arrhythmia, clinicians must monitor, evaluate and comprehensively understand their patients' needs to help them choose the optimal treatment program. This article reviews primarily about the diagnosis progress and treatment of adult CHD patients with arrhythmia.

参考文献/References:

[1] Mondesert B, Dubin AM, Khairy P. Diagnostic tools for arrhythmia detection in adults with congenital heart disease and heart failure[J]. Heart Fail Clin,2014,10(1):57-67.
[2] Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association[J]. Circulation,2013,127(1):e6-e245.
[3] Czosek RJ, Anderson J, Khoury PR, et al. Utility of ambulatory monitoring in patients with congenital heart disease[J]. Am J Cardiol,2013,111(5):723-730.
[4] Walsh EP, Bar-Cohen Y, Batra AS, et al. Recommendations for advanced fellowship training in clinical pediatric and congenital electrophysiology: a report from the training and credentialing committee of the pediatric and congenital electrophysiology society[J]. Heart Rhythm,2013,10(5):775-781.
[5] Sherwin ED, Triedman JK, Walsh EP. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts[J]. Circ Arrhythm Electrophysiol,2013,6(5):1032-1040.
[6] Suman-Horduna I, Roy D, Frasure-Smith N, et al. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure[J]. J Am Coll Cardiol,2013,61(4):455-460.
[7] Stan MN, Hess EP, Bahn RS, et al. A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease[J]. J Thyroid Res,2012,2012:210529.
[8] Koyak Z, Kroon B, de Groot JR, et al. Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias[J]. Am J Cardiol,2013,112(9):1461-1467.
[9] Skanes AC, Healey JS, Cairns JA, et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control[J]. Can J Cardiol,2012,28(2):125-136.
[10] Anderson JL, Halperin JL, Albert NM, et al. Management of patients with atrial fibrillation(compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2013,61(18):1935-1944.
[11] Gao D, Van Herendael H, Alshengeiti L, et al. Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator[J]. J Cardiovasc Pharmacol,2013,62(2):199-204.
[12] Windram JD, Siu SC, Wald RM, et al. New directives in cardiac imaging: imaging the adult with congenital heart disease[J]. Can J Cardiol,2013,29(7):830-840.
[13] Banchs JE, Baquero GA, Nickolaus MJ, et al. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease[J]. Congenit Heart Dis,2014,9(3):221-227.
[14] Russo AM, Stainback RF, Bailey SR, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance[J]. J Am Coll Cardiol,2013,61(12):1318-1368.
[15] Balaji S, Daga A, Bradley DJ, et al. An international multicenter study comparing arrhythmia prevalence between the intracardiac lateral tunnel and the extracardiac conduit type of Fontan operations[J]. J Thorac Cardiovasc Surg,2014,148(2):576-581.
[16] Patel S, Shah D, Chintala K, et al. Atrial baffle problems following the Mustard operation in children and young adults with dextro-transposition of the great arteries: the need for improved clinical detection in the current era[J]. Congenit Heart Dis,2011,6(5):466-474.
[17] Rosenberg MA, Samuel M, Thosani A, et al. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study[J]. Pacing Clin Electrophysiol,2013,36(3):328-333.
[18] Prystowsky EN, Padanilam BJ, Joshi S, et al. Ventricular arrhythmias in the absence of structural heart disease[J]. J Am Coll Cardiol,2012,59(20):1733-1744.
[19] Perry JC. Sudden cardiac death and malignant arrhythmias: the scope of the problem in adult congenital heart patients[J]. Pediatr Cardiol,2012,33(3):484-490.
[20] Janousek J, van Geldorp IE, Krupickova S, et al. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study[J]. Circulation,2013,127(5):613-623.
[21] Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology(ESC). Developed in collaboration with the European Heart Rhythm Association(EHRA)[J]. Eur Heart J,2013,34(29):2281-2329.
[22] Mondesert B, Khairy P. Implantable cardioverter-defibrillators in congenital heart disease[J]. Curr Opin Cardiol,2014,29(1):45-52.
[23] Thibault B, Ducharme A, Harel F, et al. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex >/=120 milliseconds[J]. Circulation,2011,124(25):2874-2881.
[24] Robertson JO, Lawrance CP, Maniar HS, et al. Surgical techniques used for the treatment of atrial fibrillation[J]. Circ J,2013,77(8):1941-1951.
[25] Junge C, Westhoff-Bleck M, Schoof S, et al. Comparison of late results of arterial switch versus atrial switch(mustard procedure)operation for transposition of the great arteries[J]. Am J Cardiol,2013,111(10):1505-1509.
[26] Mondesert B, Abadir S, Khairy P. Arrhythmias in adult congenital heart disease: the year in review[J]. Curr Opin Cardiol,2013,28(3):354-359.

相似文献/References:

[1]蒋娅,李波.心肌瘢痕研究进展[J].心血管病学进展,2016,(1):66.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.017]
 JIANG Ya,LI Bo.Research Progress of Myocardial Scar[J].Advances in Cardiovascular Diseases,2016,(6):66.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.017]
[2]段兴连,综述,常静,等.阻塞性睡眠呼吸暂停低通气综合征及其干预治疗对心血管疾病的临床意义[J].心血管病学进展,2016,(3):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
 DUAN Xinglian,CHANG Jing.Clinical Significance of OSAHS and Its Intervention Therapy on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
[3]李子进,综述,李景东,等.锚蛋白B在心血管系统中作用的研究进展[J].心血管病学进展,2016,(4):341.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.004]
 LI Zijin,LI Jingdong.Research Progress of Ankyrin-B in Cardiovascular System[J].Advances in Cardiovascular Diseases,2016,(6):341.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.004]
[4]公雪,综述,李晓燕,等.力竭运动对心肌组织结构及功能影响的研究进展[J].心血管病学进展,2016,(4):435.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.028]
 GONG Xue,LI Xiaoyan.Research Progress of Effect of Exhaustive Exercise on Structure and Function of Cardiac Muscle[J].Advances in Cardiovascular Diseases,2016,(6):435.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.028]
[5]梅宝菲,孔一慧,李为民.睡眠障碍与心血管疾病研究新进展[J].心血管病学进展,2015,(5):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
 MEI Baofei,KONG Yihui,LI Weimin.Relationship Between Somnipathy and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(6):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
[6]朱峰,陈铀.先天性心脏病相关肺动脉高压的治疗进展[J].心血管病学进展,2019,(6):894.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.014]
 ZHU Feng,CHEN You.Congenital Heart Disease-related Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(6):894.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.014]
[7]黄金秋 路发文 赵永康 陈宇雨 史红蕊 王萍 杨菊仙.先天性心脏病患儿营养状况及其危险因素分析[J].心血管病学进展,2020,(12):1324.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.023]
 HUANG Jinqiu,LU Fawen,ZHAO Yongkang,et al.Nutritional Status in Children with Congenital Heart Disease and the Influential Factors[J].Advances in Cardiovascular Diseases,2020,(6):1324.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.023]
[8]周玲梅 张文倩 张智伟.体-肺动脉分流术在建立先天性心脏病动物模型中的应用进展[J].心血管病学进展,2021,(7):628.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.013]
 ZHOU Lingmei,ZHANG Wenqian,ZHANG Zhiwei.Application Progress of Systemic Pulmonary Arterial Shunt in Animal Model of Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2021,(6):628.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.013]
[9]林锡祥 杨菲菲 陈煦 何昆仑.人工智能赋能医学影像在先天性心脏病医学诊治中的研究进展[J].心血管病学进展,2022,(12):1063.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.002]
 LIN Xixiang,YANG Feifei,CHEN Xu,et al.Artificial Intelligence Medical Imaging Technology in Medical Imaging of Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2022,(6):1063.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.002]
[10]刘晓旭 莫绪明.先天性心脏病患儿心肺转流术后肠道损伤机制及治疗进展[J].心血管病学进展,2023,(6):501.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.0005]
 LIU Xiaoxu,MO Xuming.Mechanism and Treatment of Intestinal Injury After Cardiopulmonary Bypass in Children with Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2023,(6):501.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.0005]

备注/Memo

备注/Memo:
基金项目:教育部创新团基金(IRT1141) 作者简介:郭琳娟(1990—),硕士,主要从事心律失常研究。Email: guolynne@126.com 通信作者:洪葵,主任医师,博士生导师,主要从事心律失常研究。Email: hongkui88@163.com
更新日期/Last Update: 2016-06-20